| Title | Nature Reviews Drug Discovery |
| Abbreviation | Nat. Rev. Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1) |
| h-index | 370 |
| Overall Rank/Ranking | 17 |
| SCImago Journal Rank (SJR) | 19.423 |
| Impact Score | 17.15 |
| Publisher | Nature Publishing Group |
| Country | United Kingdom |
| ISSN | 14741784, 14741776 |
| Best Quartile | Q1 |
| Coverage History | 2002-2022 |
Nature Reviews Drug Discovery is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1). It is published by Nature Publishing Group. The overall rank of Nature Reviews Drug Discovery is 17. According to SCImago Journal Rank (SJR), this journal is ranked 19.423. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 370. The best quartile for this journal is Q1.
The ISSN of Nature Reviews Drug Discovery journal is 14741784, 14741776. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nature Reviews Drug Discovery is cited by a total of 12260 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Nature Reviews Drug Discovery is 17.15, which is computed in 2023 as per its definition. Nature Reviews Drug Discovery IF is increased by a factor of 0.41 and approximate percentage change is 2.45% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Nature Reviews Drug Discovery is 17.15. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 17.15 |
| 2021 | 16.74 |
| 2020 | 12.24 |
| 2019 | 9.31 |
| 2018 | 8.99 |
| 2017 | 8.98 |
| 2016 | 11.62 |
| 2015 | 10.52 |
| 2014 | 9.38 |
Nature Reviews Drug Discovery has an h-index of 370. It means 370 articles of this journal have more than 370 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Nature Reviews Drug Discovery is 14741784, 14741776. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Nature Reviews Drug Discovery is 17. According to SCImago Journal Rank (SJR), this journal is ranked 19.423. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 19.423 |
| 2021 | 11.296 |
| 2020 | 9.921 |
| 2019 | 7.018 |
| 2018 | 9.483 |
| 2017 | 10.106 |
| 2016 | 12.597 |
| 2015 | 12.019 |
| 2014 | 9.338 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 17 |
| 2021 | 55 |
| 2020 | 78 |
| 2019 | 156 |
| 2018 | 85 |
| 2017 | 79 |
| 2016 | 55 |
| 2015 | 53 |
| 2014 | 92 |
Nature Reviews Drug Discovery is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2002-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Nature Reviews Drug Discovery is Nat. Rev. Drug Discov.. This abbreviation ('Nat. Rev. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Nature Reviews Drug Discovery latest impact IF is 17.15. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 17.15 (2022) and 8.98 (2017), respectively, in the last 9 years. Moreover, its average IS is 11.66 in the previous 9 years.
The Nature Reviews Drug Discovery has an SJR (SCImago Journal Rank) of 19.423, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 19.423 in 2022 and the lowest being 7.018 in 2019. Furthermore, the average SJR of the Nature Reviews Drug Discovery over the previous 9-year period stands at 11.66.
The latest h-index of the Nature Reviews Drug Discovery is 370.
The Nature Reviews Drug Discovery is published by the Nature Publishing Group, with its country of publication being the United Kingdom.
The Nature Reviews Drug Discovery is currently ranked 17 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 17 in 2022 and its lowest position of 156 in 2019.
The standard ISO4 abbreviation for the Nature Reviews Drug Discovery is Nat. Rev. Drug Discov..
Nature Reviews Drug Discovery is classified as a journal that the Nature Publishing Group publishes.
The Nature Reviews Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Nature Reviews Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 14741784, 14741776.
The best quartile for the Nature Reviews Drug Discovery is Q1 (2022).
The Nature Reviews Drug Discovery coverage history can be summarized as follows: 2002-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Journal of International Financial Management and Accounting | journal | 6179 | Wiley-Blackwell Publishing Ltd | 42 | 6.09 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Howard Journal of Communications | journal | 9564 | Taylor and Francis Ltd. | 36 | 1.66 |
| Epigenetics | journal | 2362 | Landes Bioscience | 105 | 4.11 |
| Journal des Professionnels de l'Enfance | journal | 27577 | TPMA | 2 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 17.15 |
| 2021 | 16.74 |
| 2020 | 12.24 |
| 2019 | 9.31 |
| 2018 | 8.99 |
| 2017 | 8.98 |
| 2016 | 11.62 |
| 2015 | 10.52 |
| 2014 | 9.38 |
